Navigation Links
Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
Date:6/4/2008

MOORESVILLE, N.C., June 4 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly owned subsidiary, EnviroSystems, Inc. (ESI) announced that the U.S. Environmental Protection Agency (EPA) accepted its submission to add additional claims to its disinfectant/sanitizer, EnviroTru(R) for use of the product as a sanitizer against the "superbug" MRSA (scientifically known as Methicillin Resistant Staphylococcus aureus) and VRE (scientifically known as Vancomycin Resistant Enterococcus faecalis). Having received approval from the federal EPA for these additional claims, the company has commenced the state registration process which it believes should be completed with the majority of states within 30 days.

EnviroTru(R) ( http://www.envirosi.com/products/envirotru.htm ) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner, effective against numerous organisms, and also meets EPA requirements for Toxicity Category IV (no harmful dermal, ocular, inhalation or ingestion effects). EnviroTru(R) does not require protective clothing, gloves or special ventilation and has passed the AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for non-corrosion and materials compatibility.

J. Lloyd Breedlove, President and CEO of Anpath Group, stated, "We are confident these additional claims will add to the growing market demand for EnviroTru(R). The timeliness of this registration is noteworthy considering the increased incidence of MRSA cases reported in public settings; particularly schools." Mr. Breedlove continued, "These claims are a small part of our aggressive development and testing program intended to expand our product offering. Moreover, while the ability to kill potentially harmful microorganisms is important, it is just as important that the biocide have a favorable profile for health and environmental effects. It is no
'/>"/>

SOURCE Anpath Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
2. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
3. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
4. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
5. Wound Management Technologies, Inc. Announces Evidence Based Study
6. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
7. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
8. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
9. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
10. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
11. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... British Columbia and MENLO PARK, Calif. ... (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol ... trial had been filed with the U.S. Food and Drug ... 50mg/m 2 has been opened at three clinical trial ... company also confirmed that gross proceeds of US$2.9 million have ...
(Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 /PRNewswire/ ... and ASAHI INTECC (Securities Code 7747, Second Section, ... formalized plans to develop a new, differentiated fractional flow ... a device intended to improve handling compared to existing ... emerging field in interventional cardiology that exceeds $250 million ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4
... 2010 Microfluidics International Corporation (OTC Bulletin Board: ... third quarter 2010 financial results on Tuesday, November 16, ... President and Chief Executive Officer, and Peter F. Byczko, ... host a conference call and live audio webcast. ...
... YORK, Nov. 9, 2010 Malaria No More and the ... NightWatch. Senegalese singer Youssou NDour and other international celebrities are ... celebrity voices and deliver an important nightly message about malaria. ... will use radio, television and cell phone text messaging (SMS) ...
Cached Medicine Technology:Microfluidics International Corporation to Report Third Quarter 2010 Financial Results on November 16, 2010 2World-Renowned Singer Youssou NDour Launches NightWatch Program 2
(Date:8/20/2014)... It’s no secret that millions of ... National Institute on Drug Abuse, nearly 24 million Americans ... more alarming is the fact that the total number ... Those locked in a struggle with substance abuse often ... now, the newly-redesigned AbuseTreatmentCenters.net has released updated lists of ...
(Date:8/20/2014)... The Institute for Integrative Nutrition ... to announce its new partnership with California ... university offering graduate programs featuring flexible learning. Graduates ... now eligible to receive six graduate credits towards ... , “I’m so thrilled to announce this new ...
(Date:8/20/2014)... Missouri federal judge has remanded a lawsuit filed by a ... NaturaLyte to the City of St. Louis Circuit Court, reports ... rejected an assertion by the defendants that the plaintiffs’ claims ... v. Fresenius Medical Care North America Inc., et al., No. ... of the dialysis products GranuFlo and NaturaLyte. In 2012, the ...
(Date:8/20/2014)... August 20, 2014 Botanica ... cell facial. Utilizing the new and popular stem ... targets fine lines and wrinkles and naturally repairs ... specials, highlighting the new service by offering clients ... the stem cell facial. , Pevonia® continues to ...
(Date:8/20/2014)... 2014 (HealthDay News) -- Taking the widely ... dying from heart-related causes, a new study suggests. ... the findings require urgent confirmation, said the Danish researchers ... risk is small and that guidelines for the use ... information is available. One heart expert wasn,t surprised ...
Breaking Medicine News(10 mins):Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Antibiotic Might Raise Heart Risks for Some 2
... Senate Finance Committee handed a major victory to the health ... have created a "public option" to compete against private health ... health care system. The industry has fought the public option ... the year, fearing that the proposed policy would cut into ...
... RadioShack Corporation (NYSE: RSH ) will join seven-time ... Lance Armstrong Foundation) by participating for the first time ... RadioShack plans to activate almost 6,000 store locations to ... serves nationwide. RadioShack announced earlier this year its ...
... Anchor Bay Entertainment, the successful distributor of independent ... with Susan G. Komen for the Cure(®) in the ... months, Anchor Bay Entertainment will donate $1 for each ... well as develop specialized promotions for the campaign to ...
... problems later , WEDNESDAY, Sept. 30 (HealthDay News) -- New ... reduces the risk for neurological problems later. , Unfortunately, the ... disability. , Still, the findings, appearing in the Oct. 1 ... help fill a crucial gap in the effort to treat ...
... ORLANDO, Fla., Sept. 30 In light of recent flu ... University of Central Florida (UCF) athletes got protected against the ... UCF Arena, today. UCF students from men,s and women,s ... Athletic teams came out to set an example to the ...
... Incorporated (NYSE: HR ) announced it has entered into ... previous $400 million facility. The new facility includes 16 ... priced at 2.80% over LIBOR, with a 0.40% facility fee, ... loans of this nature. , Healthcare Realty Trust ...
Cached Medicine News:Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 2Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 3Health News:RadioShack Joins With Lance Armstrong to Raise Awareness for LIVESTRONG Day on Oct. 2 2Health News:RadioShack Joins With Lance Armstrong to Raise Awareness for LIVESTRONG Day on Oct. 2 3Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 2Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 3Health News:Cooling Helps Oxygen-Deprived Newborns 2Health News:Cooling Helps Oxygen-Deprived Newborns 3Health News:UCF Athletes Set Example While Getting Protected Against Flu 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2
... Clinical Xpert™ for PDAs is a new ... Clinical Xpert puts authoritative drug, disease and ... physicians and other prescribers, nurses, pharmacists, and ... decisions at the point of care, and ...
The 3-chip MediLive Trio Eye video camera is built to adapt to changing conditions during ophthalmic surgery with features designed for workflow optimization and maximum image quality....
... A valuable new tool for ... exhibits greater dynamic range and shows ... SWAP, at the same degree of ... has been shown to correlate with ...
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
Medicine Products: